Default company panoramic image

Transluminal Technologies, LLC

Improving vascular closure through innovation in implant delivery and absorption.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Syracuse, NY, USA
  • Currency USD
  • Founded January 2008
  • Employees 6
  • Website

Company Summary

Transluminal Technologies was founded to create a true second-generation arterial puncture closure device that directly addresses the shortcomings in currently-offered products related to ease-of-use, thereby accelerating adoption rates and fueling device sales. TTL contemplates selling its unique intellectual property to an existing interventional cardiovascular device manufacturer following successful clinical trials and CE Mark approval.


  • Default avatar
    Stephen M Green

  • Default avatar
    Ronald P Caputo, MD
    Medical Director